THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...
An increase of more than 0.75 ng/mL has also been considered as a cutoff to begin a more thorough workup. However, the PSA ...
A prostate cancer survivor has said that a new screening trial for the disease is the way forward. The trial will look at how ...
The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...
A NEW prostate cancer trial is being rolled out on the NHS, aiming to find the best screening techniques to catch the deadly ...
Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.
MyOme, a leading clinical whole-genome testing and polygenic risk modeling (PRS) company, today announced the launch of its Prostate Cancer Integrated Polygenic Risk Score™ (iPRS) test — a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback